Second, the CSF2 promoter contains the consensus STAT5-binding sequence where phosphorylated STAT5 is known to persistently transactivate CSF2 gene expression in autoimmune monocytes of type 1 diabetic patients 31. This evidence concerns the gene STAT5B and type 1 diabetes mellitus.